Proteonomix Financial Statements From 2010 to 2026

PROT Stock  USD 0.0001  0.00  0.00%   
Analyzing historical trends in various income statement and balance sheet accounts from Proteonomix's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Proteonomix's valuation are summarized below:
Gross Profit
26.5 K
Market Capitalization
791
Enterprise Value Revenue
6.4187
Revenue
26 K
Revenue Per Share
0.003
There are currently one hundred twenty trending fundamental ratios for Proteonomix that can be evaluated and compared over time across competitors. All traders should check out Proteonomix's recent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 258 K in 2026. Enterprise Value is likely to drop to about 487.7 K in 2026

Proteonomix Total Revenue

22,233.42

Check Proteonomix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Proteonomix's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 655.1 K, as well as many indicators such as Price To Sales Ratio of 10.47, Dividend Yield of 0.0 or Days Sales Outstanding of 275. Proteonomix financial statements analysis is a perfect complement when working with Proteonomix Valuation or Volatility modules.
  
Build AI portfolio with Proteonomix Stock
Check out the analysis of Proteonomix Correlation against competitors.
For more information on how to buy Proteonomix Stock please use our How to Invest in Proteonomix guide.

Proteonomix Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.2 M3.8 M3.1 M
Slightly volatile
Other Current LiabilitiesM1.2 M1.6 M
Slightly volatile
Total Current Liabilities5.4 M6.3 M6.9 M
Slightly volatile
Accounts Payable1.6 M912.4 K1.1 M
Very volatile
Cash11.1211.718.8129
Slightly volatile
Net Receivables17.8 K18.7 K27.3 K
Slightly volatile
Inventory152.6 K172.3 K188.1 K
Slightly volatile
Total Liabilities5.4 M6.3 M6.9 M
Slightly volatile
Short and Long Term Debt34.8 K36.6 K60.8 K
Slightly volatile
Total Current Assets219.3 K207.2 K234.1 K
Slightly volatile
Intangible Assets1.8 M3.6 M2.9 M
Slightly volatile
Common Stock5.4 K8.8 K7.3 K
Slightly volatile
Property Plant Equipment29.2 K20.5 K24.6 K
Slightly volatile

Proteonomix Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative655.1 K689.5 KM
Slightly volatile
Total Revenue22.2 K23.4 K31.9 K
Slightly volatile
Gross Profit22.7 K23.9 K31.3 K
Slightly volatile
Research Development475.8 K610.2 K524.4 K
Slightly volatile
Total Operating Expenses1.1 M1.2 M1.5 M
Slightly volatile

Proteonomix Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings388.7 K362.9 K310.6 K
Slightly volatile
Depreciation455.3 K433.6 K363.6 K
Slightly volatile
Change To Operating Activities24 K27 K29.5 K
Slightly volatile
Total Cash From Financing Activities388.7 K362.9 K310.6 K
Slightly volatile
Change To Netincome248.9 K262 K509.9 K
Slightly volatile
Change To Liabilities516.7 K376.2 K441.4 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.479.9710.333
Slightly volatile
Days Sales Outstanding275262275
Slightly volatile
Average Payables2.4 MM1.8 M
Slightly volatile
Stock Based Compensation To Revenue2.071.972.0496
Slightly volatile
Capex To Depreciation0.110.120.1367
Slightly volatile
EV To Sales137130135
Slightly volatile
ROIC7.36.956.0543
Slightly volatile
Payables Turnover0.380.40.9477
Slightly volatile
Sales General And Administrative To Revenue36.2833.8830.5989
Very volatile
Average Inventory351.3 K217.8 K215.9 K
Very volatile
Research And Ddevelopement To Revenue19.2818.3719.068
Slightly volatile
Capex To Revenue1.391.331.3752
Slightly volatile
Cash Per Share0.00.02.0222
Slightly volatile
Days Payables Outstanding945953986
Slightly volatile
Income Quality0.180.190.3913
Slightly volatile
Intangibles To Total Assets0.870.830.8799
Slightly volatile
Current Ratio0.03570.03760.119
Slightly volatile
Receivables Turnover1.371.441.5277
Slightly volatile
Capex Per Share0.00640.00671.4011
Slightly volatile
Average Receivables74.8 K78.8 K270.8 K
Slightly volatile
Revenue Per Share0.00430.004660.8655
Slightly volatile
Interest Debt Per Share0.590.6317.056
Slightly volatile
Debt To Assets0.890.940.9861
Pretty Stable
Days Of Payables Outstanding945953986
Slightly volatile
Ebt Per Ebit0.820.951.0364
Slightly volatile
Long Term Debt To Capitalization1.71.621.69
Slightly volatile
Quick Ratio0.0060.00630.0604
Slightly volatile
Net Income Per E B T0.80.90.9826
Slightly volatile
Cash Ratio0.00.00.0072
Slightly volatile
Days Of Sales Outstanding275262275
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.91.021.1176
Slightly volatile
Fixed Asset Turnover1.251.311.5927
Slightly volatile
Debt Ratio0.890.940.9861
Pretty Stable
Price Sales Ratio10.479.9710.333
Slightly volatile
Asset Turnover0.00850.0090.0821
Slightly volatile
Gross Profit Margin0.960.920.9686
Slightly volatile

Proteonomix Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap258 K271.5 K357 K
Slightly volatile
Enterprise Value487.7 K513.3 K733 K
Slightly volatile

About Proteonomix Financial Statements

Proteonomix shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Proteonomix investors may analyze each financial statement separately, they are all interrelated. The changes in Proteonomix's assets and liabilities, for example, are also reflected in the revenues and expenses on on Proteonomix's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue23.4 K22.2 K
Cost Of Revenue(461.70)(438.61)
Stock Based Compensation To Revenue 1.97  2.07 
Sales General And Administrative To Revenue 33.88  36.28 
Research And Ddevelopement To Revenue 18.37  19.28 
Capex To Revenue 1.33  1.39 
Ebit Per Revenue(57.80)(54.91)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Proteonomix Stock Analysis

When running Proteonomix's price analysis, check to measure Proteonomix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proteonomix is operating at the current time. Most of Proteonomix's value examination focuses on studying past and present price action to predict the probability of Proteonomix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proteonomix's price. Additionally, you may evaluate how the addition of Proteonomix to your portfolios can decrease your overall portfolio volatility.